191 related articles for article (PubMed ID: 19589806)
1. Mechanistic studies of the modulation of cleavage activity of topoisomerase I by DNA adducts of mono- and bi-functional PtII complexes.
Malina J; Vrana O; Brabec V
Nucleic Acids Res; 2009 Sep; 37(16):5432-42. PubMed ID: 19589806
[TBL] [Abstract][Full Text] [Related]
2. Platinated DNA adducts enhance poisoning of DNA topoisomerase I by camptothecin.
van Waardenburg RC; de Jong LA; van Eijndhoven MA; Verseyden C; Pluim D; Jansen LE; Bjornsti MA; Schellens JH
J Biol Chem; 2004 Dec; 279(52):54502-9. PubMed ID: 15471886
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of camptothecin-induced topoisomerase I cleavage complexes by the acetaldehyde adduct N2-ethyl-2'-deoxyguanosine.
Antony S; Theruvathu JA; Brooks PJ; Lesher DT; Redinbo M; Pommier Y
Nucleic Acids Res; 2004; 32(18):5685-92. PubMed ID: 15498925
[TBL] [Abstract][Full Text] [Related]
4. Differential induction of topoisomerase I-DNA cleavage complexes by the indenoisoquinoline MJ-III-65 (NSC 706744) and camptothecin: base sequence analysis and activity against camptothecin-resistant topoisomerases I.
Antony S; Jayaraman M; Laco G; Kohlhagen G; Kohn KW; Cushman M; Pommier Y
Cancer Res; 2003 Nov; 63(21):7428-35. PubMed ID: 14612542
[TBL] [Abstract][Full Text] [Related]
5. Diversity of DNA topoisomerases I and inhibitors.
Pommier Y
Biochimie; 1998 Mar; 80(3):255-70. PubMed ID: 9615865
[TBL] [Abstract][Full Text] [Related]
6. Trapping of mammalian topoisomerase I and recombinations induced by damaged DNA containing nicks or gaps. Importance of DNA end phosphorylation and camptothecin effects.
Pourquier P; Pilon AA; Kohlhagen G; Mazumder A; Sharma A; Pommier Y
J Biol Chem; 1997 Oct; 272(42):26441-7. PubMed ID: 9334220
[TBL] [Abstract][Full Text] [Related]
7. Position-specific trapping of topoisomerase I-DNA cleavage complexes by intercalated benzo[a]- pyrene diol epoxide adducts at the 6-amino group of adenine.
Pommier Y; Laco GS; Kohlhagen G; Sayer JM; Kroth H; Jerina DM
Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10739-44. PubMed ID: 10995470
[TBL] [Abstract][Full Text] [Related]
8. Induction of topoisomerase I cleavage complexes by the vinyl chloride adduct 1,N6-ethenoadenine.
Pourquier P; Bjornsti MA; Pommier Y
J Biol Chem; 1998 Oct; 273(42):27245-9. PubMed ID: 9765247
[TBL] [Abstract][Full Text] [Related]
9. Single-Molecule Supercoil Relaxation Assay as a Screening Tool to Determine the Mechanism and Efficacy of Human Topoisomerase IB Inhibitors.
Seol Y; Zhang H; Agama K; Lorence N; Pommier Y; Neuman KC
Mol Cancer Ther; 2015 Nov; 14(11):2552-9. PubMed ID: 26351326
[TBL] [Abstract][Full Text] [Related]
10. Modulation of relaxation activity of human topoisomerases by Pt(II)-based complexes.
Pinato O; Benettazzo A; Dalla Via L; Farrell NP; Sissi C
J Inorg Biochem; 2020 Oct; 211():111178. PubMed ID: 32712380
[TBL] [Abstract][Full Text] [Related]
11. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
Kasparkova J; Novakova O; Farrell N; Brabec V
Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
[TBL] [Abstract][Full Text] [Related]
12. The modulation of topoisomerase I-mediated DNA cleavage and the induction of DNA-topoisomerase I crosslinks by crotonaldehyde-derived DNA adducts.
Dexheimer TS; Kozekova A; Rizzo CJ; Stone MP; Pommier Y
Nucleic Acids Res; 2008 Jul; 36(12):4128-36. PubMed ID: 18550580
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of topoisomerase I cleavage activity by thiol-reactive compounds: importance of vicinal cysteines 504 and 505.
Montaudon D; Palle K; Rivory LP; Robert J; Douat-Casassus C; Quideau S; Bjornsti MA; Pourquier P
J Biol Chem; 2007 May; 282(19):14403-12. PubMed ID: 17355975
[TBL] [Abstract][Full Text] [Related]
14. Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.
Fan Y; Weinstein JN; Kohn KW; Shi LM; Pommier Y
J Med Chem; 1998 Jun; 41(13):2216-26. PubMed ID: 9632354
[TBL] [Abstract][Full Text] [Related]
15. DNA cleavage assay for the identification of topoisomerase I inhibitors.
Dexheimer TS; Pommier Y
Nat Protoc; 2008; 3(11):1736-50. PubMed ID: 18927559
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of new indeno[1,2-c]isoquinolines: cytotoxic non-camptothecin topoisomerase I inhibitors.
Cushman M; Jayaraman M; Vroman JA; Fukunaga AK; Fox BM; Kohlhagen G; Strumberg D; Pommier Y
J Med Chem; 2000 Oct; 43(20):3688-98. PubMed ID: 11020283
[TBL] [Abstract][Full Text] [Related]
17. Chemical versatility of transplatin monofunctional adducts within multiple site-specifically platinated DNA.
Bernal-Méndez E; Boudvillain M; González-Vilchez F; Leng M
Biochemistry; 1997 Jun; 36(24):7281-7. PubMed ID: 9200676
[TBL] [Abstract][Full Text] [Related]
18. Proteasome-dependent processing of topoisomerase I-DNA adducts into DNA double strand breaks at arrested replication forks.
Lin CP; Ban Y; Lyu YL; Liu LF
J Biol Chem; 2009 Oct; 284(41):28084-28092. PubMed ID: 19666469
[TBL] [Abstract][Full Text] [Related]
19. Position- and orientation-specific enhancement of topoisomerase I cleavage complexes by triplex DNA structures.
Antony S; Arimondo PB; Sun JS; Pommier Y
Nucleic Acids Res; 2004; 32(17):5163-73. PubMed ID: 15469908
[TBL] [Abstract][Full Text] [Related]
20. Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.
Das SK; Ghosh A; Paul Chowdhuri S; Halder N; Rehman I; Sengupta S; Sahoo KC; Rath H; Das BB
J Med Chem; 2018 Feb; 61(3):804-817. PubMed ID: 29290109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
